COST IS THE REASON: Research finds half of Ozempic patients quit within a year. “About 52% of people in Denmark prescribed semaglutide (Ozempic, Wegovy) for weight loss stopped taking it after one year, researchers reported Saturday at a meeting of the European Association for the Study of Diabetes in Vienna. The drugs’ high cost appears to be the reason why people give them only a brief try, researchers said.”